Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study.

[1]  E. Liberopoulos,et al.  A review of the metabolic effects of sibutramine , 2005, Current medical research and opinion.

[2]  K. Elfhag,et al.  Sibutramine treatment in obesity: initial eating behaviour in relation to weight loss results and changes in mood. , 2005, Pharmacological research.

[3]  M. Elisaf,et al.  The effects of orlistat on metabolic parameters and other cardiovascular risk factors. , 2005, Diabetes & metabolism.

[4]  E. Lee,et al.  Depressive mood and abdominal fat distribution in overweight premenopausal women. , 2005, Obesity research.

[5]  D. Santor,et al.  An Item Response analysis of the Hamilton Depression Rating Scale using shared data from two pharmaceutical companies. , 2004, Journal of psychiatric research.

[6]  C. Nemeroff,et al.  Are mood disorders and obesity related? A review for the mental health professional. , 2004, The Journal of clinical psychiatry.

[7]  J. Bacaltchuk,et al.  A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. , 2003, Archives of general psychiatry.

[8]  A. Astrup,et al.  Effect of sibutramine on weight maintenance after weight loss: a randomised trial , 2000, The Lancet.

[9]  M. Sullivan,et al.  Predictors and Effects of Long-term Dieting on Mental Well-being and Weight Loss in Obese Women , 1994, Appetite.

[10]  D. King,et al.  Clinical pharmacology of sibutramine hydrochloride (BTS 54524), a new antidepressant, in healthy volunteers. , 1988, British journal of clinical pharmacology.

[11]  L. Sjöström,et al.  XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. , 2004, Diabetes care.

[12]  D. Kupfer,et al.  Obesity as a correlate of outcome in patients with bipolar I disorder. , 2003, The American journal of psychiatry.

[13]  Leonardo Franklin Fontenelle,et al.  An open-label trial of sibutramine in obese patients with binge-eating disorder. , 2002, The Journal of clinical psychiatry.